Hematology Frontier

From January 9 to 11, 2026, the 6th China Hematology Discipline Development Conference (CASH) was held in Tianjin. Coinciding with the launch of China’s 15th Five-Year Plan, the conference centered on the theme “Tianjin: Renewing Momentum, Intelligence Leading the Future.” With a forward-looking perspective, the meeting focused on the systemic evolution and ecological integration of hematology, exploring high-quality discipline development pathways and innovative models within the broader “Healthy China” framework.

From January 16–18, 2026, the CSCO Leukemia, Lymphoma, and Myeloma Expert Committee Working Meeting and the 2026 CSCO Hematologic Oncology Conference were held in Haikou. During the conference, Professor Lei Fan from Jiangsu Provincial People’s Hospital presented a comprehensive overview of the latest advances, current standards, and future directions in first-line treatment for chronic lymphocytic leukemia (CLL), offering valuable guidance for optimizing clinical management.

From January 16–18, 2026, the CSCO Leukemia, Lymphoma, and Myeloma Expert Committee Working Meeting and the 2026 CSCO Hematologic Oncology Conference were held in Haikou. Guided by the overarching vision of “Greater Hematology, Greater Public Health, and Greater Health,” CSCO’s hematology committees have built a four-pillar framework centered on standardization, clinical support, collaboration, and prognostic assessment, and a three-core value system emphasizing guideline implementation, resource decentralization, and academic empowerment.

From January 16–18, 2026, the CSCO Leukemia, Lymphoma, and Myeloma Expert Committee Working Meeting and the 2026 CSCO Hematologic Oncology Conference were held in Haikou. As a malignant plasma cell disorder predominantly affecting older adults, multiple myeloma (MM) requires continuous advancement in standardized diagnosis, scientific innovation, and patient-centered management, all of which are critical to the high-quality development of hematologic oncology in China.

From January 16–18, 2026, the CSCO Leukemia, Lymphoma, and Myeloma Expert Committee Working Meeting and the 2026 CSCO Hematologic Oncology Conference were held in Haikou. Leading experts and scholars from across China presented advances in both basic and clinical research in leukemia, lymphoma, and myeloma, addressing key challenges in real-world practice and exploring new therapeutic directions.

A Comprehensive Review of Annual Advances and Guideline Updates, and a Look Ahead at New Trends in Clinical Practice 丨Northern Breast Cancer Salon Editor’s Note As the year turns, another…

Editor’s Note At the beginning of the new year, distinguished experts gathered in Tianjin. From January 9 to 11, 2026, the 6th China Congress on the Advancement of Hematology (CASH)…

Editor’s Note At the dawn of the new year, leading experts convened in Tianjin. From January 9 to 11, 2026, the 6th China Congress on the Advancement of Hematology (CASH)…

Editor’s Note At the beginning of the new year, leading experts gathered in Tianjin. From January 9 to 11, 2026, the 6th China Congress on the Advancement of Hematology (CASH)…

With the dawn of the new year, Tianjin once again became a hub for academic exchange. From January 9 to 11, 2026, the 6th China Annual Conference on the Development of Hematology (CASH) was grandly held in Tianjin. Bringing together leading experts in hematology from China and abroad, the conference focused on disciplinary frontiers and national health strategies, fostering in-depth discussions on the latest research advances and future directions.